31. PO-0713: Conformity analysis of target-volume definition for margin-directed boost in pancreatic cancer SBRT. (April 2016) Authors: Holyoake, D.; Robinson, M.; Grose, D.; Mcintosh, D.; Sebag-Montefiore, D.; Radhakrishna, G.; Patel, N.; Mukherjee, S.; Hawkins, M. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S333 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. PO-0786: Outcomes from hypofractionated radiotherapy comparable to chemoradiotherapy in oesophageal cancer. (April 2018) Authors: Jones, C.; Spencer, K.; Hitchen, C.; Pelly, T.; Wood, B.; Hatfield, P.; Crellin, A.; Sebag-Montefiore, D.; Goody, R.; Crosby, T.; Radhakrishna, G. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S406 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. PO-0853: A method for automatic selection of parameters in NTCP modelling. (May 2017) Authors: Christophides, D.; Appelt, A.L.; Lilley, J.; Sebag-Montefiore, D. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. PO-0905: Data mining for pre-plan evaluation of organ at risk priority. (April 2018) Authors: Christophides, D.; Gilbert, A.; Appelt, A.; Lilley, J.; Sebag-Montefiore, D. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S483 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. PO-1303: Radiotherapy platform trials: accelerating our ability to answer important scientific questions. (November 2020) Authors: Gilbert, A.; Sebag-Montefiore, D.; Brown, J.; Brown, S. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S687 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
36. PO-1321 Prognostic factors for anal cancer treated with conformal radiotherapy – a systematic review. (May 2022) Authors: Theophanous, S.; Samuel, R.; Lilley, J.; Henry, A.; Sebag-Montefiore, D.; Gilbert, A.; Appelt, A. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S1115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
37. PO-1638: Treatment delivery uncertainties in rectal cancer radiotherapy – evidence-based margin estimates. (November 2020) Authors: Appelt, A.; Beasley, M.; Teo, M.; Slevin, F.; Muirhead, R.; Sebag-Montefiore, D. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S897 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
38. SP-0182: Anal cancer: current guidelines and remaining questions. (April 2016) Authors: Sebag-Montefiore, D. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
39. SP-0345: For the motion seconder. (April 2018) Authors: Sebag-Montefiore, D. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
40. SP-0490: The treatment of anal cancer. (November 2020) Authors: Sebag-Montefiore, D. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗